Tissue-type plasminogen activator-induced fibrinolysis is enhanced in patients with breast, lung, pancreas and colon cancer.

Nielsen VG, Matika RW, Ley MLB, et al. "Tissue-type plasminogen activator-induced fibrinolysis is enhanced in patients with breast, lung, pancreas and colon cancer." Blood Coagul. Fibrinolysis. 2014;25(3):248-53.